Lowe Wealth Advisors, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lowe Wealth Advisors, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$4,774
+15.7%
5310.0%0.00%0.0%
Q3 2023$4,126
-19.7%
5310.0%0.00%
-33.3%
Q2 2023$5,140
-11.7%
5310.0%0.00%0.0%
Q1 2023$5,820
+153.7%
5310.0%0.00%
+200.0%
Q4 2022$2,294
-42.6%
5310.0%0.00%
-50.0%
Q3 2022$4,000
-20.0%
5310.0%0.00%
-33.3%
Q2 2022$5,000
-28.6%
5310.0%0.00%0.0%
Q1 2022$7,000
-41.7%
5310.0%0.00%
-40.0%
Q4 2021$12,0000.0%5310.0%0.01%
-16.7%
Q3 2021$12,000
+71.4%
5310.0%0.01%
+100.0%
Q2 2021$7,0000.0%5310.0%0.00%
-25.0%
Q1 2021$7,0000.0%5310.0%0.00%0.0%
Q4 2020$7,0005310.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders